0

Antihyperlipidemic Effects of Rhapontin and Rhapontigenin From Rheum Undulatum in Rats Fed a High-Cholesterol Diet

Sung-Pil Jo, Jeong-Keun Kim, Young-Hee Lim

Planta Med. 2014 Aug;80(13):1067-71.

PMID: 25127020

Abstract:

Rhapontin was purified from a methanol extract from the roots of Rheum undulatum, and rhapontigenin was produced by an enzymatic transformation of rhapontin. Rats were fed a high-cholesterol diet to induce hyperlipidemia, followed by oral treatment with rhapontin or rhapontigenin (1-5 mg/kg/day). Rhapontin and rhapontigenin treatment resulted in a significant (p<0.05) dose-dependent decrease in the serum lipid level, while the high-density lipoprotein cholesterol level increased slightly compared with the experimental control. Furthermore, rhapontin and rhapontigenin treatment improved the pathological characteristics of the degenerating fatty liver in high-cholesterol diet-induced hyperlipidemic rats dose-dependently. Aspartate aminotransferase and alanine aminotransferase levels in rhapontin- and rhapontigenin-treated hyperlipidemic rats were not significantly different from those in the control. These results indicate that rhapontin and rhapontigenin can be used as potent antihyperlipidemic agents.

Chemicals Related in the Paper:

Catalog Number Product Name Structure CAS Number Price
AP500652 Rhapontigenin Rhapontigenin 500-65-2 Price
qrcode